MarketPulse
H

$HROW

3 articles found
1 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Harrow Raises $50M via Senior Notes as Ophthalmic Firm Funds Growth

Harrow prices $50M in senior unsecured notes due 2030, expanding existing debt facility for product development and strategic initiatives.
HROWproduct developmentcapital raise
The Motley FoolThe Motley Fool··Andy Gould

Major Shareholder Trims $7.8M Harrow Stake, Signals Profit-Taking Over Retreat

Opaleye Management sold $7.8M in $HARR shares while retaining 10% stake, suggesting tactical rebalancing rather than loss of confidence in ophthalmic pharma company.
HROWearnings missportfolio rebalancing
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Harrow to Release 2025 Financial Results on March 2

Harrow Health will release 2025 financial results March 2, 2026, reaffirming $270-$280 million revenue guidance and highlighting its expanding pharmaceutical portfolio.
HROWfinancial resultsrevenue guidance